PQR309

· PIQUR Therapeutics AG

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PQR309, covering 2017-04-12 to 2019-07-09. Get the full timeline:

Most recent: Clinical Trial Update: PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma [Phase 2]